*BrainsWay Deep TMS is not FDA-cleared to treat addiction behaviors. This webinar covers the results of clinical research being conducted
Abraham Zangen, PhD
Professor Abraham Zangen is the Head of the Brain Stimulation and Behavior Lab and the Chair of the PsychoBiology Brain Program at Ben-Gurion University in Israel. His research is directed at identifying and understanding altered neuroplasticity in psychiatric disorders – primarily depression, addiction and ADHD. Prof. Zangen has published over 150 peer reviewed articles, reviews and book chapters.